Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide

AI Summary

Eli Lilly is suing pharmacies and peptide vendors in the US over unauthorized sales of retatrutide, a promising weight-loss drug. The legal action targets distribution through medical spas and pharmacies offering compounded versions.

Some Americans have turned to medical spas and pharmacies that sell peptides for health and wellness benefits for access to compounded versions of retatrutide.